About OncoSec Medical Incorporated
OncoSec Medical Incorporated is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The Company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. As of July 31, 2016, the Company was pursuing two Phase II trials: ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma and ImmunoPulse IL-12 plus pembrolizumab in patients with advanced, metastatic melanoma. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple negative breast cancer. Its ImmunoPulse product candidates are based on its deoxyribonucleic acid (DNA)-based immunotherapy technology, which is designed to stimulate the human immune system, resulting in systemic anti-tumor immune responses.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: ONCS
- Previous Close: $1.52
- 50 Day Moving Average: $1.30
- 200 Day Moving Average: $1.55
- 52-Week Range: $1.03 - $3.49
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -1.39
- P/E Growth: 0.00
- Market Cap: $30.00M
- Outstanding Shares: 19,734,000
- Beta: 1.76
- Return on Equity: -97.82%
- Return on Assets: -83.81%
Companies Related to OncoSec Medical Incorporated:
- Current Ratio: 7.59%
- Quick Ratio: 7.59%
Earnings History for OncoSec Medical Incorporated (NASDAQ:ONCS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/6/2017|| || || || || || || || |
Earnings Estimates for OncoSec Medical Incorporated (NASDAQ:ONCS)
Current Year EPS Consensus Estimate: $-1.28 EPS
Next Year EPS Consensus Estimate: $-1.09 EPS
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for OncoSec Medical Incorporated (NASDAQ:ONCS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for OncoSec Medical Incorporated (NASDAQ:ONCS)
Insider Ownership Percentage: 11.53%
Institutional Ownership Percentage: 8.39%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/31/2017||Punit Dhillon||Insider||Buy||3,000||$0.99||$2,970.00|| |
|10/16/2015||Punit Dhillon||CEO||Buy||10,000||$4.25||$42,500.00|| |
|6/10/2015||Punit Dhillon||CEO||Buy||2,500||$6.74||$16,850.00|| |
|3/20/2014||Anthony E Maida III||Director||Buy||22,800||$0.81||$18,468.00|| |
|3/19/2014||Punit Dhillon||CEO||Buy||50,000||$0.80||$40,000.00|| |
Latest Headlines for OncoSec Medical Incorporated (NASDAQ:ONCS)
What is OncoSec Medical Incorporated's stock symbol?
OncoSec Medical Incorporated trades on the NASDAQ under the ticker symbol "ONCS."
Where is OncoSec Medical Incorporated's stock going? Where will OncoSec Medical Incorporated's stock price be in 2017?
4 analysts have issued 12 month target prices for OncoSec Medical Incorporated's stock. Their forecasts range from $5.00 to $17.00. On average, they anticipate OncoSec Medical Incorporated's share price to reach $9.33 in the next year.
When will OncoSec Medical Incorporated announce their earnings?
OncoSec Medical Incorporated is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.
Who owns OncoSec Medical Incorporated stock?
OncoSec Medical Incorporated's stock is owned by a number of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.48%).
Who sold OncoSec Medical Incorporated stock? Who is selling OncoSec Medical Incorporated stock?
OncoSec Medical Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
How do I buy OncoSec Medical Incorporated stock?
Shares of OncoSec Medical Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of OncoSec Medical Incorporated stock cost?
One share of OncoSec Medical Incorporated stock can currently be purchased for approximately $1.52.
OncoSec Medical Incorporated (NASDAQ:ONCS) Chart for Thursday, February, 23, 2017
Institutional Ownership ChartEarnings History ChartDividend History Chart